Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Åberg, Elin ^a,b   Holst, Sarah ^a   Neagu, Alexandru ^a,b   Og̈ren, Sven Ove ^a   Lavebratt, Catharina ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

AMYGDALOID NUCLEUS; ANIMAL; BAGG ALBINO MOUSE; BRAIN CORTEX; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MEMORY; MOUSE; NERVE CELL; PREGNANCY; PRENATAL EXPOSURE;

AMYGDALA; ANIMALS; CARBAMAZEPINE; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MEMORY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEURONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84893611844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080497     Document Type: Article

References (65)

1. Hauser WA (1994) The prevalence and incidence of convulsive disorders in children. Epilepsia 35 Suppl 2: S1-6.
2. Wallace H, Shorvon S, Tallis R (1998) Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and agespecific fertility rates of women with epilepsy. Lancet 352: 1970-1973. (Pubitemid 29000863)
3. Crawford P, Appleton R, Betts T, Duncan J, Guthrie E, et al. (1999) Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure: the journal of the British Epilepsy Association 8: 201-217.
4. Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G (1998) Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39: 887-892. (Pubitemid 128721656)
5. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, et al. (2001) The teratogenicity of anticonvulsant drugs. The New England journal of medicine 344: 1132-1138. (Pubitemid 32285234)
6. Samren EB, van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, et al. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38: 981-990. (Pubitemid 27382935)
7. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Annals of neurology 46: 739-746. (Pubitemid 29518135)
8. Kaneko S, Battino D, Andermann E, Wada K, Kan R, et al. (1999) Congenital malformations due to antiepileptic drugs. Epilepsy research 33: 145-158. (Pubitemid 29143352)
9. Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J (2004) Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane database of systematic reviews: CD004848.
10. Galbally M, Roberts M, Buist A (2010) Mood stabilizers in pregnancy: a systematic review. The Australian and New Zealand journal of psychiatry 44: 967-977.
11. Gentile S (2011) Drug treatment for mood disorders in pregnancy. Current opinion in psychiatry 24: 34-40.
12. Gentile S (2010) Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depression and anxiety 27: 675-686.
13. Kaplan PW, Norwitz ER, Ben-Menachem E, Pennell PB, Druzin M, et al. (2007) Obstetric risks for women with epilepsy during pregnancy. Epilepsy & behavior: E&B 11: 283-291.
14. Meador KJ, Pennell PB, Harden CL, Gordon JC, Tomson T, et al. (2008) Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 71: 1109-1117.
15. Pennell PB (2004) Pregnancy in women who have epilepsy. Neurologic clinics 22: 799-820.
16. Morrow JI, Hunt SJ, Russell AJ, Smithson WH, Parsons L, et al. (2009) Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. Journal of neurology, neurosurgery, and psychiatry 80: 506-511.
17. Meador KJ, Baker G, Cohen MJ, Gaily E, Westerveld M (2007) Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy & behavior: E&B 11: 292-302.
18. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, et al. (2009) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. The New England journal of medicine 360: 1597-1605.
19. Bromley RL, Baker GA, Meador KJ (2009) Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Current opinion in neurology 22: 162-166.
20. Adab N, Kini U, Vinten J, Ayres J, Baker G, et al. (2004) The longer term outcome of children born to mothers with epilepsy. Journal of neurology, neurosurgery, and psychiatry 75: 1575-1583. (Pubitemid 39430610)
21. Pennell PB (2008) Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? Epilepsia 49 Suppl 9: 43-55.
22. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, et al. (2009) Management issues for women with epilepsy-Focus on pregnancy (an evidencebased review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50: 1237-1246.
23. Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, et al. (2009) Antiepileptic drug use in women of childbearing age. Epilepsy & behavior: E&B 15: 339-343.
24. Banach R, Boskovic R, Einarson T, Koren G (2010) Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies. Drug safety: an international journal of medical toxicology and drug experience 33: 73-79.
25. Vinten J, Bromley RL, Taylor J, Adab N, Kini U, et al. (2009) The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy & behavior: E&B 14: 197-201.
26. Vinten J, Adab N, Kini U, Gorry J, Gregg J, et al. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64: 949-954. (Pubitemid 40388441)
27. Eriksson K, Viinikainen K, Monkkonen A, Aikia M, Nieminen P, et al. (2005) Children exposed to valproate in utero-population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy research 65: 189-200. (Pubitemid 41187573)
28. Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George B, et al. (2008) Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy & behavior: E&B 13: 229-236.
29. Adab N, Jacoby A, Smith D, Chadwick D (2001) Additional educational needs in children born to mothers with epilepsy. Journal of neurology, neurosurgery, and psychiatry 70: 15-21. (Pubitemid 32096115)
30. Titze K, Koch S, Helge H, Lehmkuhl U, Rauh H, et al. (2008) Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Developmental medicine and child neurology 50: 117-122.
31. Dessens A, Cohen-Kettenis P, Mellenbergh G, van de Poll N, Koppe J, et al. (1998) Prenatal exposure to anticonvulsant drugs and spatial ability in adulthood. Acta neurobiologiae experimentalis 58: 221-225. (Pubitemid 28432657)
32. Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG (1999) Late cognitive effects of early treatment with phenobarbital. Clinical pediatrics 38: 387-394. (Pubitemid 29328298)
33. Reinisch JM, Sanders SA, Mortensen EL, Rubin DB (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA: the journal of the American Medical Association 274: 1518-1525.
34. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, et al. (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proceedings of the National Academy of Sciences of the United States of America 99: 15089-15094. (Pubitemid 35334614)
35. Chen J, Cai F, Cao J, Zhang X, Li S (2009) Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. Journal of neuroscience research 87: 2898-2907.
36. Kim J, Kondratyev A, Gale K (2007) Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. The Journal of pharmacology and experimental therapeutics 323: 165-173. (Pubitemid 47443273)
37. Almgren M, Kallen B, Lavebratt C (2009) Population-based study of antiepileptic drug exposure in utero-influence on head circumference in newborns. Seizure: the journal of the British Epilepsy Association 18: 672-675.
38. Jones KL, Lacro RV, Johnson KA, Adams J (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. The New England journal of medicine 320: 1661-1666. (Pubitemid 19154591)
39. Ornoy A, Cohen E (1996) Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Archives of disease in childhood 75: 517-520.
40. Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, et al. (2002) Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. Journal of medical genetics 39: 251-259. (Pubitemid 34496801)
41. Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J (2011) Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Archives of disease in childhood 96: 643-647.
42. Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, et al. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62: 28-32. (Pubitemid 38082865)
43. Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, et al. (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA: the journal of the American Medical Association 271: 767-770.
44. Baarendse PJ, van Grootheest G, Jansen RF, Pieneman AW, Ogren SO, et al. (2008) Differential involvement of the dorsal hippocampus in passive avoidance in C57bl/6J and DBA/2J mice. Hippocampus 18: 11-19.
45. Stiedl O, Misane I, Spiess J, Ogren SO (2000) Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. The Journal of neuroscience: the official journal of the Society for Neuroscience 20: 8515-8527.
46. Lavebratt C, Trifunovski A, Persson AS, Wang FH, Klason T, et al. (2006) Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouse. Neurobiology of disease 24: 374-383. (Pubitemid 44604336)
47. West MJ, Gundersen HJ (1990) Unbiased stereological estimation of the number of neurons in the human hippocampus. The Journal of comparative neurology 296: 1-22. (Pubitemid 20174971)
48. West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. The Anatomical record 231: 482-497.
49. Paxinos G, Halliday G, Watson C, Koutcherov Y, Wang H (2007) Atlas of the Developing mouse brain. Academic Press, Elsevier.
50. Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
51. LeDoux JE (1993) Emotional memory systems in the brain. Behavioural brain research 58: 69-79.
52. Madjid N, Tottie EE, Luttgen M, Meister B, Sandin J, et al. (2006) 5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms. The Journal of pharmacology and experimental therapeutics 316: 581-591. (Pubitemid 43130984)
53. Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, et al. (2008) Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology 54: 1041-1050.
54. Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS (1997) The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends in neurosciences 20: 464-470. (Pubitemid 27421709)
55. Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A, Ben-Ari Y (1996) Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity. Trends in neurosciences 19: 109-114.
56. Crepel V, Epsztein J, Ben-Ari Y (2003) Ischemia induces short- and long-term remodeling of synaptic activity in the hippocampus. Journal of cellular and molecular medicine 7: 401-407. (Pubitemid 44151690)
57. Bayer SA, Altman J (1974) Hippocampal development in the rat: cytogenesis and morphogenesis examined with autoradiography and low-level X-irradiation. The Journal of comparative neurology 158: 55-79.
58. Dobbing J, Sands J (1979) Comparative aspects of the brain growth spurt. Early human development 3: 79-83. (Pubitemid 9141710)
59. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. Journal of neuroscience methods 11: 47-60.
60. D'Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain research Brain research reviews 36: 60-90. (Pubitemid 32763130)
61. Lepicard EM, Joubert C, Hagneau I, Perez-Diaz F, Chapouthier G (2000) Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice. Pharmacology, biochemistry, and behavior 67: 739-748. (Pubitemid 32144924)
62. Ohl F, Sillaber I, Binder E, Keck ME, Holsboer F (2001) Differential analysis of behavior and diazepam-induced alterations in C57BL/6N and BALB/c mice using the modified hole board test. Journal of psychiatric research 35: 147-154. (Pubitemid 32672856)
63. Perez Martin JM, Fernandez Freire P, Labrador V, Hazen MJ (2008) Carbamazepine induces mitotic arrest in mammalian Vero cells. Mutation research 637: 124-133. (Pubitemid 350256770)
64. Quinn R (2005) Comparing rat's to human's age: how old is my rat in people years? Nutrition 21: 775-777.
65. Dwyer JB, McQuown SC, Leslie FM (2009) The dynamic effects of nicotine on the developing brain. Pharmacology & therapeutics 122: 125-139.